Limited Neutralization of Omicron by Antibodies from the BNT162b2 Vaccination against SARS-CoV-2

Since early December 2021, the omicron variant has posed additional challenges to the world-wide management of the SARS-CoV-2 pandemic. Immune evasion is a key factor for its increased transmissibility. While serological studies have measured levels of neutralizing antibodies in response to vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanz, Tobias V., Brewer, R. Camille, Jahanbani, Shaghayegh, Robinson, William H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016652/
https://www.ncbi.nlm.nih.gov/pubmed/35441169
http://dx.doi.org/10.21203/rs.3.rs-1518378/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016652/
https://www.ncbi.nlm.nih.gov/pubmed/35441169
http://dx.doi.org/10.21203/rs.3.rs-1518378/v1

Ejemplares similares